Maintenance of GPIIb-IIIa avidity supporting 'irreversible' fibrinogen binding is energy-dependent

Journal of Laboratory and Clinical Medicine

Volumn 134, Issue 4, 1999, Pages 398-404

  Peerschke, Ellinor I B ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b New York Presbyterian Veterans Administration   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033214292     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90155-5     Document Type: Article

References (32)

1. 1. Peerschke EIB, Zucker MB, Grant TA, Egan JJ, Johnson MM. Correlation between fibrinogen binding to human platelets and platelet aggregation. Blood 1980;55:841-7.
2. 2. Landolfi R, DeCristofaro R, DiCandia E, Rocca B, Bizz B. Effect of fibrinogen concentration on the velocity of platelet aggregation. Blood 1991;78:377-81.
3. 3. Naik UP, Parise LV. Structure and function of platelet αIIbβ3. Curr Opin Hematol 1997;4:317-22.
4. 3 integrin (Platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Regulation 1990;1:883-93.
5. 5. Sims PJ, Ginsberg MH, Plow EF, Shattil SJ. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem 1991;266:7345-52.
6. 6. Savage B, Ruggerie ZM. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on non-activated platelets. J Biol Chem 1991;266:11227-33.
7. 7. Blockmans D, Deckmyn H, Vermulen J. Platelet activation. Blood Rev 1995;9:143-56.
8. 8. Shattil SJ, Ginsberg MH, Brugge JS. Adhesive signaling in platelets. Curr Opin Cell Biol 1994;6:695-704.
9. 9. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-12.
10. 10. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: The platelet paradigm. Blood 1998;91:2645-57.
11. 3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp 125FAK. J Cell Biol 1993;122:473-83.
12. 12. Peerschke EIB. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets. Thromb Hemost 1995;73:862-7.
13. 13. Kovacsovics, Bachelot C, Toker A, Vlahos CJ, Duckworth B, Cantley LC, Hartwig JH. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. J Biol Chem 1995;270:11358-66.
14. 14. Peerschke EIB. Events occurring after fibrinogen binding to thrombin stimulated platelets. Semin Thromb Hemost 1992;18:1834-43.
15. 15. Peerschke EIB. Bound fibrinogen distribution on stimulated platelets. Examination by confocal scanning laser microscopy. Am J Pathol 1995;147:678-87.
16. 16. Wencel-Drake JD, Boudignon-Proudhon C, Dieter MG, Criss AB, Parise LV. Internalization of bound fibrinogen modulates platelet aggregation. Blood 1996;87:602-12.
17. 17. Peerschke EIB. Decreased accessibility of platelet bound fibrinogen to antibody and enzyme probes. Blood 1989;74:682-9.
18. 18. Muller B, Zerwes HG, Tangemann K, Peter J, Engel J. Two step binding mechanism of fibrinogen to alpha IIb/beta3 integrin reconstituted into planar lipid bilayers. J Biol Chem 1993;268:6800-8.
19. 19. Peerschke EIB. Stabilization of platelet-fibrinogcn interactions is an integral property of the glycoprotein IIb-IIIa complex. J Lab Clin Med 1994;124:439-46.
20. 20. Peerschke EIB. Effect of stimulation on the stabilization of platelet fibrinogen interactions. Thromb Haemost 1992;68: 346-51.
21. 21. Smyth SS, Hillery CA, Parise LV. Fibrinogen binding to purified platelet glycoprotein IIB-IIIa (integrin alphaIIbbeta3) is modulated by lipids. J Biol Chem 1992;267:15568-77.
22. 22. Peerschke EIB. Time dependent association between platelet-bound fibrinogen and the Triton X-100 insoluble cytoskeleton. Blood 1992;79:2028-33.
23. 23. Parker RI, Gralnick HR. Energy-dependent expression of platelet-von Willebrand factor on the surface of unstimulated and stimulated platelets. J Lab Clin Med 1997;130:520-9.
24. 24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227: 680-5.
25. 25. Peerschke EIB. The platelet fibrinogen receptor. Semin Hematol 1985;22:241-59.
26. 26. Metzelaar MJ, Wijngaard PJ, Peters PF, Sixma JJ, Niewenhuis HK, Clevers HC. CD63 Antigen. A novel lysosomal membrane glycoprotein cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 1991;266:3239-45.
27. 3. J Cell Biol 1998;141:1685-95.
28. 28. Peerschke EIB, Wainer JA. Examination of irreversible platelet fibrinogen interactions. Am J Physiol 1985;248: C466-472.
29. 3 and its ligand and induces selective movements of ligand-occupied integrin. J Biol Chem 1996;271:7004.
30. 30. Sorisky A, King W, Rittenhouse S. Accumulation of PtdIns(3,4)P2 and PtdIns(3,4,5)P3 in thrombin-stimulated platelets. Different sensitivities to Ca2+ or functional integrin. Biochem J 1992;286:581-4.
31. 31. Sultan C, Plantavid M, Bachelot C, Grondin P, Breton M, Mauco G, et al. Involvement of platelet glycoprotein IIb-IIIa (alpha IIb-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3′,4′-biphosphate. J Biol Chem 1991; 266:23554-7.
32. 32. Peerschke EI, Zucker MB. Fibrinogen receptor exposure and aggregation of human blood platelets produced by ADP and chilling. Blood 1981;57:663-9.